Longeveron (LGVN) EBIT (QoQ) (2020 - 2026)
Longeveron (LGVN) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.56% |
| Dec 31, 2025 | 26.14% |
| Sep 30, 2025 | -35.45% |
| Jun 30, 2025 | -4.17% |
| Mar 31, 2025 | -21.02% |
| Dec 31, 2024 | 7.92% |
| Sep 30, 2024 | -32.83% |
| Jun 30, 2024 | 14.43% |
| Mar 31, 2024 | 24.82% |
| Dec 31, 2023 | -5.41% |
| Sep 30, 2023 | 9.65% |
| Jun 30, 2023 | -21.12% |
| Mar 31, 2023 | 10.02% |
| Dec 31, 2022 | -1.04% |
| Sep 30, 2022 | -22.89% |
| Jun 30, 2022 | -24.37% |
| Mar 31, 2022 | 15.82% |
| Dec 31, 2021 | 17.80% |
| Sep 30, 2021 | 3.10% |
| Jun 30, 2021 | -46.39% |